Human Genome Sciences (NASDAQ: HGSI) is a biopharmaceutical corporation founded in 1992. Its stated purpose is to “discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs.” The company focuses on drug development, as well as drug discovery and currently (as of 2008) has a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. It has historically pursued collaborations with other biotechnology and pharmaceutical companies, for development partnerships and technology licensing .
HGSI currently has three (3) drugs in Phase III human testing: LymphoStat-B (belimumab) for lupus, Albuferon for Hepatitis C, and Abthrax (raxibacumab) for anthrax disease.
Source: Wikipedia
Popular on Twitter:
breonnaxearrr: human genome sciences #human http://bit.ly/nQkZt
kaileejoio: human genome sciences #genome http://bit.ly/nQkZt
yyz2: http://if10.net/0cf Human Genome Sciences
alxmancilla: Human Genome Sciences Inc. confirms its experimental lupus drug, called Benlysta, successfully passed its latest round of testing.
FlashDriveLover: Wall Street Journal Human Genome: Lupus Drug Meets Goal: Human Genome Sciences stock tripled .. http://bit.ly/CdYJ9
dorethagenam: human genome sciences #sciences http://kashmirsentinel.com
Dubli4U: Human Genome: Lupus Drug Meets Goal: Human Genome Sciences stock tripled in early Monday trading as it said its .. http://bit.ly/nwrQn
StemCellSuccess: Biotech/Pharma Stocks Sector Close- Up- Human Genome Sciences … http://bit.ly/4EnVmf
HotOnes10: hmmmm is human genome sciences really that important to you x today really????
option_maestro: Human Genome: Lupus Drug Meets Goal: Human Genome Sciences stock tripled in early Monday trading as it said its .. http://bit.ly/nwrQn
hilarylohe: human genome sciences #sciences http://bit.ly/nQkZt
shielaneobee: human genome sciences #genome http://bit.ly/nQkZt
Lupus09: HGS’s Lupus Drug Successfully Passes Clinical Trial: By Mike Musgrove Shares of Human Genome Sciences Inc. s.. http://bit.ly/ynEBS
diannjenme: RT WSJ – Human Genome Sciences, Glaxo Report Success With Lupus Drug http://bit.ly/cKr6D
mg_health: HGS’s Lupus Drug Successfully Passes Clinical Trial: Shares of Human Genome Sciences Inc. soared Monday followin.. http://bit.ly/1tEpu
Human Genome Sciences Blog Results
- Human Genome Sciences HGSI Stock Quote News Analysis | Online Tips …
HGSI Human Genome Sciences, Inc is a good stock to buy, Sell or Hold? Get all the news, analysis and recommendations on HGSI Stock Symbol from Yahoo finance and Google Finance. Read more - Lupus Drug Revives Human Genome Sciences' Prospects | Today's Drum …
Benlysta is first new medicine to succeed against disease in 50 years. Benlysta improved symptoms of lupus without any sign of worsening others in an. Read more - Benlysta | Human Genome Sciences | Human Genome
goxy.us benlysta,human genome sciences, human genome, hgsi, cit stock, brisbane tv Washington Post Benlysta Effective in Some Lupus Sufferers BusinessWeek The experimental lupus drug Benlysta has defied skeptics by significantly …Read more - Exponential Price/Volume Alert: Human Genome Sciences (HGSI)
Human Genome Sciences Inc. (NASDAQ: HGSI) is going to be the top price leader this morning. It and GlaxoSmithKline (GSK) have announced that the BENLYSTA study met the primary endpoint in BLISS-52, the first of two pivotal Phase III … Read more - Human Genome Sciences and GlaxoSmithKline Announce Positive Phase …
Human,Genome,Sciences,and,GlaxoSmithKline,Announce,Positive,Phase,3,Study,Results,for,BENLYSTA(TM),in,Systemic,Lupus,Erythematosus,medicine,advanced medical technology,medical laboratory technology,medical device technology,latest … Read more - Human Genome Sciences and GlaxoSmithKline Announce Positive Phase …
The forward-looking statements are based on Human Genome Sciences’ current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult … Read more
Human Genome Sciences Videos
[tubepress mode='tag', tagValue='human genome sciences']